Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Operational Update next post S&P 500 Bullish Patterns: Are Higher Highs Ahead? You may also like Trump Admin Fast Tracks Anfield’s Velvet-Wood Uranium Project... May 16, 2025 Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025 Westport Publishes Annual General and Special Meeting Results May 16, 2025 Development update – Collie graphite micronising facility June 3, 2025 Satellite Imagery and Gold Exploration June 5, 2025 Finlay Minerals Announces Increase in Size of Non-Brokered... June 5, 2025 Precious Metals & Critical Minerals Hybrid Investor Conference:... May 25, 2025 Scoping Study Demonstrates Low Cost ISR Uranium Potential June 5, 2025 Harmony Gold to Acquire MAC Copper in US$1.03... June 2, 2025 Harvest Gold Soil Sampling Program Reveals Several New... May 23, 2025